Mount Sinai Medical Scientist Training Program
Mount Sinai Medical Scientist Training Program
批准号:
10652661
负责人:
Talia H Swartz
金额:
$139.33万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30
中文摘要
西奈山伊坎医学院医学科学家培训计划的使命是
在一个严格的、综合的双学位课程中培养不同的未来医生-科学家干部,为
他们将通过在各种临床专科和职业生涯中为改善人类健康做出贡献
生物医学研究环境。该计划以包容和协作的环境为特色,促进
基础和转化型生物医学研究的创新。我们有成就的学生团体被选为
来自高素质和多样化的申请者池,来自各种背景的学生,他们来自重要的
以前的研究经验。实习生留任率高,人员流失率低,平均达到8
好几年了。有意改变我们的招生和招聘做法,包括更全面的审查和
其他代表性不足群体中女性和学生的录取目标人数增加,已经
导致他们在过去五年的预科学生中和在更大的MSTP中的代表性增加。这个
拟议的计划包括显著提高机构支持水平,反映在教师人数的增加上
指导MSTP的工作和人员配备,并增加财政支持(使用单独的计划预算)
学生培训和其他活动,以促进团队精神和内科科学家的发展
认同感;一个高度整合的课程,侧重于科学知识的实验基础和它的
翻译应用;更多地使用团队建设活动;创新的研究生院课程,
将重点放在发展量化和计算技能、创业精神、
人工智能等新兴技术,以及严格和可重复的研究设计培训
在整个方案中;更加重视从临床前到博士培训的过渡,并继续
改进长期课程,促进平稳过渡到临床培训;加强
与管道方案建立伙伴关系,以增强MSTP学生群体的多样性,并提供
从医学院进入该项目的替代途径;MSTP学生有资格获得早期保障
研究跟踪西奈山的常驻方案;改进导师培训和监测机制
学生的进步和满意度。我们的短期和中期目标是提供包容和多样化的
培训环境将使我们的学生继续取得高水平的成就,即使不是超越,也是平等的
过去5年学生取得的成就,以出版物衡量,获得独立奖学金
在顶级派驻计划中提供支持和匹配。虽然我们的大部分校友(82%)都在攻读基础课程,
学术、制药、生物技术和联邦机构的转译和/或临床研究,我们的
我们的长期目标是让更多的毕业生成为独立的调查人员和领导人,他们在
与人类健康和疾病相关的重要研究问题,并将其发现转化为战略
在所有社区和更广泛的职业领域预防和治疗疾病。
英文摘要
The mission of the Medical Scientist Training Program at the Icahn School of Medicine at Mount Sinai is to
educate a diverse cadre of future physician-scientists in a rigorous, integrated dual degree program that prepares
them to contribute to the improvement of human health through careers in a variety of clinical specialties and
biomedical research environments. The program features an inclusive and collaborative environment that fosters
innovation in fundamental and translational biomedical research. Our accomplished student body is selected
from a highly qualified and diverse applicant pool of students from all backgrounds who come with significant
prior research experience. Trainee retention has been high and attrition low, with average time to degree of 8
years. Intentional changes in our admissions and recruitment practices, including a more holistic review and
increased acceptance target numbers for women and students in other under-represented groups, have already
resulted in their increased representation among matriculants of the past five years and in the larger MSTP. The
proposed program includes a significantly increased level of institutional support, reflected in increased faculty
effort and staffing to direct the MSTP and increased financial support (with a separate program budget) for
student training and other activities that promote esprit de corps and the development of a physician-scientist
identity; a well-integrated curriculum that focuses on the experimental basis of scientific knowledge and on its
translational applications; increased use of team building activities; innovative graduate school curriculum that
incorporates a strong emphasis on development of quantitative and computational skills, entrepreneurship,
emerging technologies such as artificial intelligence, and training in rigorous and reproducible research design
throughout the program; increased attention to the transition from preclinical to PhD training and continued
improvements in a longstanding course that promotes a smooth transition to clinical training; strengthened
partnerships with pipeline programs to enhance the diversity of the MSTP student population and to provide
alternative pathways into the program from the medical school; MSTP student eligibility for early assurance
research track residency programs at Mount Sinai; and improved mentor training and mechanisms for monitoring
student progress and satisfaction. Our short- and intermediate-term goals are to provide an inclusive and diverse
training environment that will allow our students to continue to achieve at a high level and to equal if not surpass
the achievements of students of the past 5 years, as measured by publications, receipt of independent fellowship
support, and matching in top residency programs. While a large percentage of our alumni (82%) pursue basic,
translational, and/or clinical research in academic, pharmaceutical, biotechnology, and federal agencies, our
long-term goal is for more of our graduates to become independent investigators and leaders who address
important research questions related to human health and disease and translate their discoveries into strategies
for the prevention and therapy of disease in all communities and in an expanded array of career sectors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation
-
批准号:10655438
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
Dissecting the mechanisms of HIV-1 infection and inflammatory signaling in human lymphoid tissue
-
批准号:10224031
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation
-
批准号:10397211
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation
-
批准号:10085494
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation
-
批准号:10440432
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation
-
批准号:10226334
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
Dissecting the mechanisms of HIV-1 infection and inflammatory signaling in human lymphoid tissue
-
批准号:10081720
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2020
-
负责人:Talia H Swartz
-
依托单位:
海外基金